MARKET WIRE NEWS

Outperform Recommendation Issued On CRMD By Leerink Partners

Source: KlickAnalytics

2026-03-06 18:15:04 ET

  • Leerink Partners analyst issues OUTPERFORM recommendation for CRMD on March 6, 2026 08:13PM ET.
  • The previous analyst recommendation was Outperform.
  • CRMD was trading at $6.46 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 6 - Buy recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations < ...
    Full story available on KlickAnalytics.com
    CorMedix Inc.

    NASDAQ: CRMD

    CRMD Trading

    4.57% G/L:

    $6.755 Last:

    810,411 Volume:

    $6.62 Open:

    mwn-ir Ad 300

    CRMD Latest News

    CRMD Stock Data

    $605,887,756
    76,346,585
    2.82%
    76
    N/A
    Biotechnology & Life Sciences
    Healthcare
    US
    Berkeley Heights

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App